Exact Mass: 1220.6189516
Exact Mass Matches: 1220.6189516
Found 84 metabolites which its exact mass value is equals to given mass value 1220.6189516,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Matesaponin 4
Matesaponin 4 is found in tea. Matesaponin 4 is a constituent of mat leaf (Ilex paraguariensis). Constituent of maté leaf (Ilex paraguariensis). Matesaponin 4 is found in tea.
Pulchinenoside B4
Hederacoside C
CDP-DG(i-22:0/LTE4)
CDP-DG(i-22:0/LTE4) is an oxidized CDP-diacylglycerol (CDP-DG). Oxidized CDP-diacylglycerols are glycerophospholipids in which a cytidine diphosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized CDP-diacylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. CDP-DG(i-22:0/LTE4), in particular, consists of one chain of one 20-methylheneicosanoyl at the C-1 position and one chain of Leukotriene E4 at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized CDP-DGs can be synthesized via three different routes. In one route, the oxidized CDP-DG is synthetized de novo following the same mechanisms as for CDP-DGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the CDP-DG backbone, mainly through the action of LOX (PMID: 33329396).
CDP-DG(LTE4/i-22:0)
CDP-DG(LTE4/i-22:0) is an oxidized CDP-diacylglycerol (CDP-DG). Oxidized CDP-diacylglycerols are glycerophospholipids in which a cytidine diphosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized CDP-diacylglycerols belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, CDP-diacylglycerols can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. CDP-DG(LTE4/i-22:0), in particular, consists of one chain of one Leukotriene E4 at the C-1 position and one chain of 20-methylheneicosanoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized CDP-DGs can be synthesized via three different routes. In one route, the oxidized CDP-DG is synthetized de novo following the same mechanisms as for CDP-DGs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the CDP-DG backbone, mainly through the action of LOX (PMID: 33329396).
(3beta,4alpha,22beta)-22-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid
(3beta,4alpha,22beta)-22-[[2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-3-yl o-6-deoxy-alpha-l-mannopyranosyl-(1->2)-o-beta-d-galactopyranosyl-(1->2)-beta-d-glucopyranosiduronic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). (3beta,4alpha,22beta)-22-[[2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-3-yl o-6-deoxy-alpha-l-mannopyranosyl-(1->2)-o-beta-d-galactopyranosyl-(1->2)-beta-d-glucopyranosiduronic acid can be found in soy bean, which makes (3beta,4alpha,22beta)-22-[[2-o-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-3-yl o-6-deoxy-alpha-l-mannopyranosyl-(1->2)-o-beta-d-galactopyranosyl-(1->2)-beta-d-glucopyranosiduronic acid a potential biomarker for the consumption of this food product.
anemoside B4
Pulchinenoside C (Anemoside B4) is Pulsatilla koreana Nakai that have many numerous biological effects in vitro, including enhancing hypoglycemic, anti-tumor, neuroprotective and anti-angiogenic activity. Pulchinenoside C (Anemoside B4) is Pulsatilla koreana Nakai that have many numerous biological effects in vitro, including enhancing hypoglycemic, anti-tumor, neuroprotective and anti-angiogenic activity.
Hederacol
Kalopanaxsaponin B is a triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus. It has a role as an anti-inflammatory agent and a plant metabolite. It is a pentacyclic triterpenoid, a triterpenoid saponin and a carboxylic ester. It is functionally related to a hederagenin. Hederacoside C is a natural product found in Hedera caucasigena, Akebia trifoliata, and other organisms with data available. See also: Hedera helix leaf (part of). A triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus. Hederacoside C (Kalopanaxsaponin B) is the main bioactive molecular component of ivy leaves. It has expectorant, bronchodilator, antibacterial and other effects and can be used to study respiratory diseases. Hederacoside C (Kalopanaxsaponin B) is the main bioactive molecular component of ivy leaves. It has expectorant, bronchodilator, antibacterial and other effects and can be used to study respiratory diseases.
Anemoside
Pulchinenoside C (Anemoside B4) is Pulsatilla koreana Nakai that have many numerous biological effects in vitro, including enhancing hypoglycemic, anti-tumor, neuroprotective and anti-angiogenic activity. Pulchinenoside C (Anemoside B4) is Pulsatilla koreana Nakai that have many numerous biological effects in vitro, including enhancing hypoglycemic, anti-tumor, neuroprotective and anti-angiogenic activity.
Hederacoside C
Annotation level-1 Hederacoside C (Kalopanaxsaponin B) is the main bioactive molecular component of ivy leaves. It has expectorant, bronchodilator, antibacterial and other effects and can be used to study respiratory diseases. Hederacoside C (Kalopanaxsaponin B) is the main bioactive molecular component of ivy leaves. It has expectorant, bronchodilator, antibacterial and other effects and can be used to study respiratory diseases.
>
[3,4-dihydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxyoxan-2-yl)oxyoxan-2-yl] (4aS,6aS,6bR,10S,12aR)-10-[5-[3,5-dihydroxy-6-(hydroxymethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
3beta-hydroxyolean-12-en-28-oic acid 3-O-{[alpha-L-rhamnopyranosyl(1->2)][beta-D-xylopyranosyl(1->2)-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl(1->3)]-beta-D-glucopyranoside}
3beta-O-(alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl)-23-hydroxylup-12-en-28-O-(alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->6)-beta-D-galactopyranosyl) ester
3-O-alpha-L-rhamnopyranosyl(1-2)[beta-D-glucopyranosyl(1-3)]-alpha-L-arabinopyranosyloleanolic acid 28-O-beta-D-glucopyranosyl(1-6)-beta-D-glucopyranoside|mateglycoside A|O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl 3-[(O-beta-D-glucopyranosyl-(1->3)-O-[alpha-L-rhamnopyranosyl-(1->2)]-alpha-L-arabinopyranosyl)oxy]olean-12-en-28-oate
(3beta,4alpha,22beta)-22-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-alpha-L-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->2)-beta-D-glucopyranosiduronic acid
3-O-(alpha-L-arabinopyranosyl-(1-2)-alpha-L-arabinopyranosyl)-olean-12-ene-28,29-dioic acid-28-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside|3-O--olean-12-ene-28,29-dioic acid-28-O-alpha-L-rhamnopyranosyl-(1-4)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside
3-O-alpha-D-galactopyranosyl(1->2)-alpha-L-arabinosyl ursolic acid 28-O-alpha-L-rhamnopyranosyl(1->4)-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl ester|cussosaponin E
26-O-beta-D-glucopyranosyl-22-O-methyl-(25R)-furost-5-ene-1beta,3beta,22,26-tetrol 1-O-[O-beta-D-glucopyranosyl-(1->3)-O-alpha-L-rhamnopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galactopyranoside]
3-O-beta-D-glucopyranosyl-oleanolic acid-28-O-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)]-beta-D-xylopyranoside
3-beta-[(beta-D-glucopyranosyl-(1->3)-O-alpha-L-arabinopyranosyl)-oxy]-23-hydroxy-30-norolean-12-en-28-oic acid alpha-L-rhamnopyranosyl(1->4)-O-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl ester|Mutangsaponin D
7,10-di-(O-rhodosaminyl-deoxyfucosyl-deoxyfucosyl)-beta-rhodomycinone
(3b)-3-{[beta-D-glucopyranosyl-(1?3)-6-deoxy-alpha-L-mannopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-6-deoxy-alpha-L-mannopyranosyl-(1?2)-alpha-L-arabinopyranosyl]oxy}-23-hydroxyolean-12-en-28-oic acid|3-O-[beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-alpha-L-arabinopyranosyl]hederagenin
3-O-?-D-glucopyranosyl(1?4)-?-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)[?-D-glucopyranosyl(1?4)]-alpha-L-arabinopyranosyloleanolic acid|3-O-beta-D-glucopyranosyl (1?4)-beta-D-glucopyranosyl (1?3)-alpha-L-rhamnopyranosyl (1?2)[beta-D-glucopyranosyl(1?4)]-alpha-L-arabinopyranosyl oleanolic acid|3-O-[beta-D-glucopyranosyl(1?4)-beta-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)[beta-D-glucopyranosyl(1?4)]-alpha-L-arabinopyranosyl]oleanolic acid|3-O-{beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)-[beta-D-glucopyranosyl-(1->4)]-alpha-L-arabinopyranosyl}oleanolic acid
16-O-(S)-2-methylbutyroyl-A1-barrigenol 3-O-beta-D-glucopyranosyl(1?2)-[alpha-L-rhamnopyranosyl(1?2)-beta-D-galactopyranosyl(1?3)]-beta-D-glucuronopyranoside|sanchakasaponin B
3-O-[beta-D-glucopyranosyl-(1?2)]-[alpha-L-arabinopyranosyl-(1?3)]-[alpha-L-arabinofuranosyl-(1?4)]-beta-D-glucuronopyranosyloleanolic acid 28-O-beta-D-glucopyranosyl ester|senaciapittoside A
3beta-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl]oleanoic acid 28-O-[beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl] ester
12-O-cinnamoyl-20-O-tigloyl-(20S)-pregn-6-ene-3beta,5alpha,8beta,12beta,14beta,17beta,20-heptanol 3-O-beta-D-glucopyranosyl-(1->4)-6-deoxy-3-O-methyl-beta-D-allopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside|mucronatoside G
hederagenin 3-O-[O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1->6)-O-beta-D-glucopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranoside]
3-O-beta-D-glucopyranosyl-(1-3)-O-alpha-L-arabinopyranoside of 28-O-alpha-L-rhamnopyranosyl-(1-4)-O-beta-gentiobiosyl ether of ursolic acid
3-O-[??-D-Glucopyranosyl-(1鈥樏傗垎4)][??-L-rhamnopyranosyl-(1鈥樏傗垎3)]-??-D-glucopyranosyl-(1鈥樏傗垎3)-??-L-rhamnopyranosyl-(1鈥樏傗垎2)-??-arabinoyranosyl-hederagenin
3-O-alpha-L-rhamnopyranosyl-(1-2)-O-alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl ester of ursolic acid
3-O-alpha-L-rhamnopyranosyl-(1-2)-O-alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1-4)-O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranosyl ester of oleanolic acid
(3beta,16alpha)-28-{[O-beta-D-glucopyranosyl-1-(1->3)-O-beta-D-xylopyranosyl-(1->4)-O-6-deoxy-alpha-L-mannopyranosyl-(1->2)-alpha-L-arabinopyranosyl]oxy}-16-hydroxy-28-oxolean-12-en-3-yl beta-D-glucopyranosiduronic acid|foetidissimoside C
C59H96O26_6-Deoxy-alpha-L-mannopyranosyl-(1->3)-beta-D-xylopyranosyl-(1->4)-6-deoxy-alpha-L-mannopyranosyl-(1->2)-6-deoxy-1-O-{(2beta,3beta,5xi,9xi,16alpha)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-2,16,23-trihydroxy-28-oxoolean-12-en-28-yl}-beta-D-galactopyranose
Matesaponin 4
1-O-[(3?,5?,9?,18?)-3-{[Hexopyranosyl-(1->3)hexopyranosyl-(1->4)-6-deoxyhexopyranosyl]oxy}-28-oxoolean-12-en-28-yl]-4-O-pentopyranosylhexopyranose
(2S,3S,4S,5R)-6-[[(3S,4aR,6aR,6bS,8R,8aR,12aS,14aR,14bR)-8a-[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6S)-5-[(2S,3R,4S,5R)-3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,4-dihydroxy-6-methyloxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxycarbonyl-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
[6-[[3,4-dihydroxy-6-(hydroxymethyl)-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aR,6aR,6aS,6bR,9R,12aR,14bR)-10-[4,5-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl] (4aS,6aS,6bR,9R,10S,12aR)-10-[(3R,4S,5S)-4,5-dihydroxy-3-[(3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylate
Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2
C55H80N16O16 (1220.5937920000001)
Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 (FS-6) is a fluorescent peptide that is a quenched MMP peptide substrate. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 can be used for real-time quantification of MMP enzymatic activity. Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 is an elongated peptide of MMP substrate (FS-1) and is active against collagenases (MMP-1, MMP-8, MMP-13 ) and MT1-MMP with higher specificity constants than FS-1[1]. (Ex/Em=325 nm/400 nm)
Pentixafor
C60H80N14O14 (1220.5978140000002)
Pentixafor is a peptide that targets CXCR4. Pentixafor is capable of being labelled with 68Gallium (68Ga) for positron emission tomography (PET) imaging[1].